| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.04 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.05 |